Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: Rationale and design of a randomized controlled trial
Title:
Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: Rationale and design of a randomized controlled trial
Author:
Haff, Nancy Horn, Daniel M Bhatkhande, Gauri Sung, Meekang Colling, Caitlin Wood, Wendy Robertson, Ted Gaposchkin, Daniel Simmons, Leigh Yang, Judy Yeh, James Crum, Katherine L. Hanken, Kaitlin E. Lauffenburger, Julie C. Choudhry, Niteesh K.